ALPEK, S.A.B. de C.V.

ALPEK, S.A.B. de C.V.

ALPKF
ALPEK, S.A.B. de C.V.US flagOther OTC
0.77
USD
- -
- -
1.61BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
42.52
40.64
39.47
42.6
46.76
63.51
56.54
53.95
74
100.78
65.57
65.22
60.85
110.12
Basic EPS, GAAP
0.12
0.38
1.3
1.71
-2.59
6.44
3.12
1.48
3.67
6.52
-5.18
-0.36
-1.33
-1.28
Free Cash Flow per Basic Share
1.54
1.13
2.27
0.02
1.32
2.83
3.23
4.42
4.17
5.75
5.92
2
2.46
2
Dividend per Share
1.39
- -
0.7
0.93
1.26
- -
1.31
1.28
1.76
3.53
1.41
1.2
0.32
1.03
Book Value per Share
6.77
7.05
7.58
8.19
4.59
10.99
12.6
12.81
14.5
17.58
11.07
9.4
7.83
9.23
Tangible Book Value per Share
11.42
11.22
12.13
14.1
13.04
18.32
19.5
19.82
21.9
22.66
14.11
14.16
11.85
13.9
Basic Weighted Avg Shares
2,118
2,118
2,118
2,117
2,117
2,118
2,117
2,113
2,111
2,108
2,107
2,107
2,085
2,105
Sales/Revenue/Turnover
90,061
86,072
83,590
90,192
98,998
134,523
119,685
113,989
156,224
212,435
138,159
137,409
126,840
231,807
Operating Margin (%)
6.06
4.38
8.8
10.68
6.64
9.44
6.77
5.54
11.94
11.34
3.22
4.13
1.95
2.83
Depreciation Expense
2,025
1,839
2,254
2,560
2,635
2,885
4,005
4,486
4,280
4,639
4,619
4,767
5,158
5,173
Net Income, GAAP
262
801
2,748
3,625
-5,487
13,633
6,605
3,123
7,756
13,744
-10,914
-765
-2,774
-2,693
Effective Tax Rate (%)
47.42
40.19
35.76
32.08
- -
18.79
20.07
22.58
28.75
25.65
- -
- -
- -
238.73
Profit Margin (%)
0.29
0.93
3.29
4.02
-5.54
10.13
5.52
2.74
4.96
6.47
-7.9
-0.56
-2.19
-1.16
Working Capital
17,367
16,616
17,736
14,814
14,173
12,539
23,254
24,197
26,110
20,483
19,113
18,822
17,822
19,464
LT Debt
13,756
15,666
18,276
21,551
26,958
30,012
30,559
32,502
32,208
34,172
35,403
42,094
38,031
39,746
Total Equity
27,088
29,845
34,499
41,722
31,664
43,163
45,058
45,512
49,586
52,194
33,222
33,505
27,585
32,494
Return on Invested Capital (%)
6.65
5.11
9.35
10.79
- -
13.87
7.94
6.16
15.85
19.43
- -
- -
- -
-11.78
Return on Capital (%)
0.41
2.3
6.54
7.02
- -
23.64
11.48
5.69
10.4
16.59
- -
- -
- -
-13.83
Return on Common Equity (%)
1.67
5.47
17.73
21.71
-40.56
82.61
26.44
11.62
26.89
40.62
-36.16
-3.55
-15.36
-12.51

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
2,580
1,993
4,309
LT Borrowings
38,934
40,156
36,956
LT Finance Leases
3,160
3,029
2,790
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,107
2,101
2,101
Market Capitalization
32,947
32,291
22,416

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
54,172
55,932
51,417
Cash, Cash Equivalents & STI
6,382
7,200
8,303
Accounts Receivable, Net
16,060
13,704
11,927
Inventories
28,244
29,593
25,761
Total Current Liabilities
35,350
35,487
31,953
Payables & Accruals
- -
- -
- -
ST Debt
2,580
1,993
4,309
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.04%
-7.79%
-17.67%
Free Cash Flow
730.85%
-2%
21.21%
Net Income, GAAP
-45.64%
43.15%
262.61%
Sales/Revenue/Turnover
6.76%
5.97%
-7.69%
Total Cash Common Dividend
- -
-2.18%
-73.68%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
32,349
33,042
37,156
126,840
137,409
2025
35,022
32,789
27,957
- -
126,840
2026
29,762
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.1
0.23
-1.32
-0.36
2025
0.08
-0.27
-0.75
- -
-1.33
2026
-0.54
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
1.31
-0.27
1.2
2025
- -
- -
0.22
- -
0.32
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Jorge Pedro Young Cerecedo
Full Time Employees
5,514
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
Avenida GOmez MorIn Sur No. 1111 San Pedro Garza Garcia NL Mexico 66254
IPO Date
Dec 13, 2016
Website
alpek.com
Business
Alpek, S.A.B. de C.V. is a leading integrated petrochemical company primarily engaged in the production and commercialization of petrochemical products. The company manufactures and markets a diversified portfolio including polyethylene terephthalate (PET), purified terephthalic acid (PTA), expandable polystyrene (EPS), and polypropylene (PP). It also produces caprolactam and other intermediate chemicals used in manufacturing various plastics and synthetic fibers. Alpek’s product offerings serve multiple end markets, including packaging, textiles, automotive, appliances, and construction industries, with operations primarily across Mexico, the United States, Brazil, Argentina, and Chile. Founded in 1975 and headquartered in Monterrey, Mexico, Alpek operates through an integrated business model that includes polyethylene terephthalate resin, polyester fibers, and chemicals production plants. The company is part of the Alfa Group, a major Mexican conglomerate. Recent developments within the last couple of years include strategic investments to expand production capacities in PTA and PET to meet growing demand, along with operational enhancements and sustainability initiatives. Alpek has strengthened partnerships within the petrochemical industry to enhance its competitive positioning and product innovation capabilities while expanding its footprint in key growth markets. Alpek’s business segments cover PET and Polyester, Chemicals, and Plastics, with a focus on innovation, operational efficiency, and geographical diversification to support its regional leadership in petrochemicals. Its highly integrated manufacturing operations and extensive distribution network allow it to serve a broad range of industrial clients in North and South America. The company consistently leverages technological advancements to maintain product quality and environmental compliance, reinforcing its status as a significant player in the petrochemical sector.

Company News

APIChatGPT
  • ALPEK, S.A.B. de C.V. (ALPKF) Q1 2026 Earnings Call Transcript

  • ALPEK, S.A.B. de C.V. (ALPKF) Q4 2025 Earnings Call Transcript

  • ALPEK, S.A.B. de C.V. (ALPKF) Q3 2025 Earnings Call Transcript

  • ALPEK Still Profitable In Worst Part Of The Cycle, Trades At Low Valuation

  • ALPEK Is Strong In The Down Cycle And Remains A Buy

  • Alfa|SIGMA reports Comparable EBITDA of US $1 billion in 2024, with Alpek as Discontinued Operations

  • Alfa|SIGMA reports 3Q24 EBITDA of US $275 million, up 13% vs 3Q23, with Alpek as Discontinued Operations

  • Shareholders approve the spin-off of ALFA's entire stake in Alpek